FDA releases final regenerative medicine guidances

FDA Friday released final versions of two guidance documents that are intended to facilitate the development of regenerative medicines.

Draft versions of the Evaluation of Devices Used with

Read the full 282 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE